The recent advances in proteomic instrumentation, methods and informatics have created exciting opportunities in all fields of diabetes research. The information on protein identification and structure provided by mass spectrometry is applicable to nearly all aspects of diabetes and its complications. Mass spectrometry-based proteomics has accelerated the identification of posttranslational modifications, including phosphorylation-site mapping, identification of protein-protein interactions, and changes in protein abundance or compartmentalization, just to name a few examples. However, the rapid rates of growth and change in proteomic technologies have also led to challenges in the translation and availability of these technologies to researchers, from new postdoctoral research fellows to established investigators who are not directly involved in this field. Although many of the fundamental principles of mass spectrometry are relatively straightforward, successful mass spectrometry-based proteomic analysis requires the combination of appropriate experimental design, access to state-of-the-art instrumentation, rigorous analysis of spectral data, and for some studies, bioinformatics tools to manage and interpret large datasets. Indeed, mass spectrometry-based proteomics is a multi-step process, and study design, from the perspectives of mass spectrometry data acquisition and interpretation, plays an important role in experimental success. The overall objective of the Proteomics Core is to provide Joslin researchers with assistance through the workflow of proteomics studies, including experimental design, sample preparation, mass spectrometric analysis, data analysis and interpretation, and bioinformatic tools. The specific objectives of Joslin's Proteomics Core are the following: 1) To assist and provide training in experimental design for proteomics studies. 2) To provide routine and custom mass spectroscopy-based proteomic analyses. 3) To assist with mass spectra analysis, interpretation, and database matching. 4) To develop a results database and incorporate access to bioinformatic tools for the analysis of proteomics data into the results database.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK036836-24
Application #
8060626
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2010-04-01
Budget End
2011-03-31
Support Year
24
Fiscal Year
2010
Total Cost
$133,310
Indirect Cost
Name
Joslin Diabetes Center
Department
Type
DUNS #
071723084
City
Boston
State
MA
Country
United States
Zip Code
02215
Kim, Youngjo; Bayona, Princess Wendy; Kim, Miri et al. (2018) Macrophage Lamin A/C Regulates Inflammation and the Development of Obesity-Induced Insulin Resistance. Front Immunol 9:696
Espeland, Mark A; Carmichael, Owen; Hayden, Kathleen et al. (2018) Long-term Impact of Weight Loss Intervention on Changes in Cognitive Function: Exploratory Analyses from the Action for Health in Diabetes Randomized Controlled Clinical Trial. J Gerontol A Biol Sci Med Sci 73:484-491
Aguayo-Mazzucato, Cristina; Bonner-Weir, Susan (2018) Pancreatic ? Cell Regeneration as a Possible Therapy for Diabetes. Cell Metab 27:57-67
Mulla, Christopher M; Middelbeek, Roeland J W; Patti, Mary-Elizabeth (2018) Mechanisms of weight loss and improved metabolism following bariatric surgery. Ann N Y Acad Sci 1411:53-64
Laffel, L (2018) Lost in transition: finding a path forward for young adults with Type 1 diabetes. Diabet Med 35:1061-1062
Skupien, Jan; Smiles, Adam M; Valo, Erkka et al. (2018) Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy. Diabetes Care :
Bauman, Viviana; Sturkey, Adaya C; Sherafat-Kazemzadeh, Rosa et al. (2018) Factitious hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes 19:823-831
Rao, Tata Nageswara; Gupta, Manoj K; Softic, Samir et al. (2018) Attenuation of PKC? enhances metabolic activity and promotes expansion of blood progenitors. EMBO J 37:
Park, Kyoungmin; Li, Qian; Evcimen, Net Da? et al. (2018) Exogenous Insulin Infusion Can Decrease Atherosclerosis in Diabetic Rodents by Improving Lipids, Inflammation, and Endothelial Function. Arterioscler Thromb Vasc Biol 38:92-101
Stanford, Kristin I; Rasmussen, Morten; Baer, Lisa A et al. (2018) Paternal Exercise Improves Glucose Metabolism in Adult Offspring. Diabetes 67:2530-2540

Showing the most recent 10 out of 1120 publications